Cancer Progress and Priorities: Gastric Cancer—Reply
- 1 September 2023
- journal article
- letter
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 32 (9) , 1271
Abstract
We thank Tavakkoli and colleagues for their interest in our recent review of gastric cancer progress and priorities (1), which included discussion of the higher gastric cancer incidence rates among all racial and ethnic minorities compared with non-Hispanic Whites, and specifically higher mortality rates among Black and Hispanic patients with non-cardia gastric cancer. We concluded that persistent disparities in incidence and mortality warrant risk-stratified prevention and interception strategies. We recognize the point raised by Tavakkoli and colleagues that, while we also reviewed the trend of increasing incidence of early-onset non-cardia gastric cancer among non-Hispanic White women, we did not acknowledge the mounting evidence of a similar trend among Hispanic White persons in the United States. We greatly appreciate Tavakkoli and colleagues bringing our attention to this important aspect of the changing demographics of early-onset non-cardia gastric cancer, and the need for additional research to understand, and ultimately prevent, this highly fatal disease that disproportionately affects racial and ethnic minorities.See the original Letter to the Editor, p. 1270P. Alagesan reports grants from Stead Fellowship during the conduct of the study. J.C. Goodwin reports grants from Emerson Collective outside the submitted work. M. Epplein reports grants from NCI, NIH during the conduct of the study. No disclosures were reported by the other author.This work was supported by Duke Cancer Disparities P20 (CA251657) and the P30 (CA014236) grants through the Duke Cancer Institute.Keywords
Funding Information
- National Cancer Institute (CA251657)
- National Cancer Institute (CA014236)
This publication has 1 reference indexed in Scilit:
- Cancer Progress and Priorities: Gastric CancerCancer Epidemiology, Biomarkers & Prevention, 2023